What a Brilliant move by Leo and Menon back in 2015 when they decided not to run a $30,000,000 P3 ABSSSI trial and instead set out to prove the anti inflammatory properties of Brilacidin for 2 different lucrative indications, OM and UP at much lower trial costs.
The success of those 2 trials now has IPIX on the verge of a MONSTER deal.

Brilliant simply Brilliant!!!!